33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multimodal single-cell profiling defines the epigenetic determinants of chronic lymphocytic leukemia evolution
    Meeting Abstract

    Chaligne, R.; Gaiti, F.; Izzo, F.; Kothen-Hill, S.; Gu, H.; Huang, K.; Risso, D.; Schulman, R.; Brand, R. M.; Lee, S. C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Mosunetuzumab, a full-length bispecific CD20/CD3 antibody, displays clinical activity in relapsed/refractory B-cell non-Hodgkin lymphoma (NHL): Interim safety and efficacy results from a phase 1 study
    Meeting Abstract

    Budde, L. E.; Sehn, L. H.; Assouline, S.; Flinn, I. W.; Isufi, I.; Yoon, S. S.; Kim, W. S.; Matasar, M. J.; Nastoupil, L. J.; Santiago, R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Ibrutinib treatment in Waldenström's macroglobulinemia: Follow-up efficacy and safety from the iNNOVATE™ study
    Meeting Abstract

    Buske, C.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C. S.; Palomba, M. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Initial report of the beat AML umbrella study for previously untreated AML: Evidence of feasibility and early success in molecularly driven phase 1 and 2 studies
    Meeting Abstract

    Burd, A.; Levine, R. L.; Shoben, A.; Mims, A. S.; Borate, U.; Stein, E. M.; Patel, P. A.; Baer, M. R.; Stock, W.; Deininger, M. W.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Genomic landscape of multiple myeloma with elevated lactate dehydrogenase
    Meeting Abstract

    Bal, S.; Girnius, S. K.; Starczynowski, D. T.; Landau, H. J.; Choi, K.
    Blood (2018)

    Fulltext@MSK | Save
  • A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) - Interim analysis of 1.5 µci/kg/dose
    Meeting Abstract

    Atallah, E. L.; Orozco, J. J.; Craig, M.; Levy, M. Y.; Finn, L. E.; Khan, S. S.; Perl, A. E.; Park, J. H.; Roboz, G. J.; Tse, W.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Mapping the evolution of T cell transcriptional states during DLI response and resistance using single-cell data
    Meeting Abstract

    Bachireddy, P.; Azizi, E.; Nguyen, V. N.; Li, S.; Neuberg, D. S.; Soiffer, R. J.; Ritz, J.; Alyea, E. P. 3rd; Pe'er, D.; Wu, C. J.
    Blood (2018)

    Fulltext@MSK | Save
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
    Meeting Abstract

    Armand, P.; Chen, Y. B.; Redd, R. A.; Joyce, R. M.; Bsat, J.; Merryman, R. W.; Coleman, K.; Dahi, P. B.; Nieto, Y.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save